Trials / Recruiting
RecruitingNCT07009951
Impact of Virtual Reality in Cardiac Electrophysiology
Acute Clinical Outcomes Following the Implementation of Virtual Reality (VR) in the Electrophysiology Laboratory
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Calabria · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pain during pacemaker or defibrillator implantation can increase patient discomfort, anxiety, and the need for deeper sedation. Using virtual reality (VR) as a non-pharmacological distraction tool may help reduce perceived pain, stabilize vital signs, and improve the overall patient experience. This prospective, single-center study evaluates whether adding VR to standard sedation lowers pain levels compared to sedation alone. Patients undergoing device implantation will be randomized to either group, with pain and vital signs monitored throughout the procedure. The study also explores patient satisfaction, adverse effects, and the potential of VR to support same-day discharge after minimally invasive procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual reality | VR headset provides an immersive environment, such as natural landscapes accompanied by relaxing music. The use of VR will begin at least five minutes before the start of the procedure to allow the patient to acclimate. The headset will remain in use throughout the entire procedure, unless complications arise (e.g., nausea or significant discomfort). |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
- First posted
- 2025-06-08
- Last updated
- 2025-08-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07009951. Inclusion in this directory is not an endorsement.